Goldman Sachs’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $624K | Buy |
430,070
+259,721
| +152% | +$377K | ﹤0.01% | 4140 |
|
|
2025
Q1 | $235K | Buy |
170,349
+9,676
| +6% | +$13.4K | ﹤0.01% | 4614 |
|
|
2024
Q4 | $488K | Buy |
160,673
+2,049
| +1% | +$6.23K | ﹤0.01% | 4311 |
|
|
2024
Q3 | $790K | Buy |
158,624
+123,356
| +350% | +$614K | ﹤0.01% | 3889 |
|
|
2024
Q2 | $206K | Sell |
35,268
-224,880
| -86% | -$1.32M | ﹤0.01% | 4357 |
|
|
2024
Q1 | $2.07M | Buy |
260,148
+229,863
| +759% | +$1.83M | ﹤0.01% | 3185 |
|
|
2023
Q4 | $177K | Buy |
+30,285
| New | +$177K | ﹤0.01% | 4366 |
|
|
2021
Q4 | – | Sell |
-11,531
| Closed | -$96K | – | 5679 |
|
|
2021
Q3 | $96K | Buy |
+11,531
| New | +$96K | ﹤0.01% | 5064 |
|